Related references
Note: Only part of the references are listed.NK cells for cancer immunotherapy
Noriko Shimasaki et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Pan-cancer characterization of immune-related lncRNAs identifies potential oncogenic biomarkers
Yongsheng Li et al.
NATURE COMMUNICATIONS (2020)
How Machine Learning Will Transform Biomedicine
Jeremy Goecks et al.
CELL (2020)
Treatment after progression in the era of immunotherapy
Salem Billan et al.
LANCET ONCOLOGY (2020)
Predictive value of single-nucleotide polymorphism signature for recurrence in localised renal cell carcinoma: a retrospective analysis and multicentre validation study
Jin-Huan Wei et al.
LANCET ONCOLOGY (2019)
Immunotherapy in colorectal cancer: rationale, challenges and potential
Karuna Ganesh et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis
Chen Wei et al.
MOLECULAR CANCER (2019)
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
Jerome Galon et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Development and validation of an immune gene-set based Prognostic signature in ovarian cancer
Sipeng Shen et al.
EBIOMEDICINE (2019)
MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside
Kenneth K. W. To et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
A systematic atlas of chaperome deregulation topologies across the human cancer landscape
Ali Hadizadeh Esfahani et al.
PLOS COMPUTATIONAL BIOLOGY (2018)
ImmPort, toward repurposing of open access immunological assay data for translational and clinical research
Sanchita Bhattacharya et al.
SCIENTIFIC DATA (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
Peng Jiang et al.
NATURE MEDICINE (2018)
Modeling the prevention of colorectal cancer from the combined impact of host and behavioral risk factors
Matthew Frampton et al.
GENETICS IN MEDICINE (2017)
Discovering novel pharmacogenomic biomarkers by imputing drug response in cancer patients from large genomics studies
Paul Geeleher et al.
GENOME RESEARCH (2017)
Non-Coding RNAs as Predictive Biomarkers to Current Treatment in Metastatic Colorectal Cancer
Ingrid Garajova et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study
Michael J. Overman et al.
LANCET ONCOLOGY (2017)
Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
Pornpimol Charoentong et al.
CELL REPORTS (2017)
Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung Cancer
Bailiang Li et al.
JAMA ONCOLOGY (2017)
MicroRNAs: Novel immunotherapeutic targets in colorectal carcinoma
Xiang Li et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Combination cancer immunotherapy and new immunomodulatory targets
Kathleen M. Mahoney et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
MicroRNA-200c Promotes Suppressive Potential of Myeloid-Derived Suppressor Cells by Modulating PTEN and FOG2 Expression
Shiyue Mei et al.
PLOS ONE (2015)
Subclass Mapping: Identifying Common Subtypes in Independent Disease Data Sets
Yujin Hoshida et al.
PLOS ONE (2007)
Share Paper
